Skip to content

DARPA – Biological Technologies Broad Agency Announcement – HR001126S003

Home / Funding Opportunity / DARPA – Biological Technologies Broad Agency Announcement – HR001126S003

DARPA – Biological Technologies Broad Agency Announcement – HR001126S003

twitterlinkedin

DARPA’s Biological Technologies Office is seeking abstract proposals that leverage biological properties and processes to revolutionise the ability to protect warfighters.

BTO harnesses advances in artificial intelligence (AI) and machine learning (ML) to create new opportunities for transformative science across the biological spectrum. Warfighter health and well-being are critical to mission success. BTO develops diagnostic and assessment systems to identify chemical and biological threats, medical countermeasures, and novel approaches to tactical care and warfighter performance and recovery on and off the battlefield. BTO also leverages biological processes, technologies, and manufacturing opportunities to create resilient infrastructures and supply chains, protective solutions, and innovative sensors to ensure mission success in any location.

Areas of interest include specific topics under the following general areas:

  • Machine learning and AI
  • Combat casualty care
  • Human performance
  • Materials, sensors, processing
  • Agricultural and environmental
  • Security, safety and surveillance
  • Biomedical and biodefense

Abstracts will be accepted and assessed on a rolling basis until 30 September 2026.

 

Read more

Document

BAA – Biological Technologies – HR001126S0003

You may be also interested in ...